Consensus MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Market Closed - Nyse Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
2.89 ^USD	-4.93%		-8.25%	+147.01%

Apr. 26	Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	MT
Apr. 22	MAIA Biotechnology, Inc. announced that it expects to receive $0.664994 million in funding	CI

Evolution of the average Target Price on MAIA Biotechnology, Inc.

Price target over the last 5 years

History of analyst recommendation changes

904359f729caf8b190e4c47e1ed9f._FS-fy8L7B5nfWY3QBE9w-_bLVib1VmPkESlvMJYhso.tyzQIAJMunM9KRQDMGJ2rpe-bw-thAnj5Cbf34o24JuSFvsuGCaefT8lDQ~894f623bb23fe2a0b24fa26f270c5223

Analyst Recommendations on MAIA Biotechnology, Inc.

Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	Apr. 26	MT
Noble Capital Starts MAIA Biotechnology at Outperform With $14 Price Target	23-02-21	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.04 USD

Average target price

12.62 USD

Spread / Average Target

+315.30%

High Price Target

14 USD

Spread / Highest target

+360.53%

Low Price Target

11.25 USD

Spread / Lowest Target

+270.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MAIA Biotechnology, Inc.

Noble Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar